Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
4/3/2026
Earendil Advances AI-Designed TL1A Antibody Into Mid-Stage UC Trial
4/3/2026
BDGene Secures Strategic Financing, Relocates Headquarters to Hangzhou...
4/3/2026
Yifan/Evive Expands Ryzneuta Europe Footprint With France Licensing De...
4/3/2026
XellSmart Secures CNY 500M+ to Accelerate Parkinson's, ALS and SCI iPS...
4/3/2026
Myeloid Cure Biotech Secures Over CNY 150M in Series A to Advance Mac...
4/3/2026
Recent Executive Moves
4/3/2026
Hengrui Unveils Promising Phase 1 Data for FIC Dual-Target Psoriasis A...
4/3/2026
NMPA Suspends Import, Sale and Use of Cadila's Amlodipine Besylate API...
4/2/2026
NMPA Issues Notice on Advancing Segmented Manufacturing of Biologics
4/2/2026
NMPA Releases Implementation Opinions on "AI + Drug Regulation"
4/1/2026
Abbisko Wins EMA Orphan Drug Designation for Irpagratinib in Liver Can...
4/1/2026
Erasca Secures Worldwide Rights to Joyo's Pan-RAS Molecular Glue with ...
4/1/2026
Pierre Fabre Deepens China Commitment as Pharma and Dermo-Cosmetics Gr...
4/1/2026
Fosun Pharma Wins China Trial Nod for Teva-Partnered FXB0871
4/1/2026
China Tightens Health Insurance Fund Oversight With New Anti-Fraud Rul...
4/1/2026
China CDE Opens Public Consultation on 105th Batch of Chemical Generic...
4/1/2026
Bayer Secures Nearly Five-Year China Patent Extension for Kerendia
4/1/2026
Alphamab and CSPC Win Phase III Breast Cancer Success for KN026 Neo-He...
4/1/2026
Salubris Unveils Long-Acting Blood Pressure siRNA Data at ACC 2026
4/1/2026
Biotech VCs Move Upstream in China as Competition for Innovation Inten...
3/31/2026
Simcere Highlights Late-Breaking Phase III Success for Rademikibart in...
3/31/2026
Innovent Publishes Strong Phase II Mazdutide 9 mg Obesity Data as Chin...
3/31/2026
Santen Accelerates China Strategy by Moving Earlier Into Global Ophtha...
3/31/2026
China's Innovative Drug Out-Licensing Nears Half of 2025 Total in Firs...
3/31/2026
Braveheart Bio Posts Promising Mid-Stage China Data for HCM Drug Licen...
3/31/2026
Connect Biopharma Reports Promising Late-Stage China Results for Eczem...
3/31/2026
Huahui Launches World's First Approved Hepatitis D Antibody Drug in Ch...
3/31/2026
CK Life Sciences Moves to Fast-Track China Cancer Vaccine Development ...
3/31/2026
NMPA Moves to Strengthen China's Conditional Drug Approval Framework
3/31/2026
NHSA Deepens Dialogue With MNC Pharma on Innovation Drug Value and Rea...
Page:
6
/
830
Total number of articles:
24896
:
[First]
[<<]
[4]
[5]
[6]
[7]
[8]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit